Quantcast

Latest Aethlon Medical Inc. Stories

2011-07-14 16:35:00

SAN DIEGO, July 14, 2011 /PRNewswire/ -- Aethlon Medical, Inc., (OTCBB: AEMD) disclosed today that its Chairman and CEO, James A. Joyce, has issued the following letter to shareholders. (Photo: http://photos.prnewswire.com/prnh/20090325/LA88762LOGO-b) To our Shareholders: Last December, I authored a shareholder letter which referenced the viewpoint of healthcare leaders who felt a need for innovative new therapeutic strategies to evolve as escalating regulatory costs, challenges and...

2011-06-21 07:04:00

SAN DIEGO, June 21, 2011 /PRNewswire/ -- Aethlon Medical, Inc. (OTCBB: AEMD), the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announces that Chairman and CEO James A. Joyce will present at tomorrow's RedChip Small-Cap Equities Virtual Conference VIII. The live webcast presentation will begin at 10:45 a.m. Pacific time (1:45 p.m. Eastern time) on Wednesday, June 22, 2011, and can be accessed online at: http://redchip.com (Photo:...

2011-06-07 16:00:00

SAN DIEGO, June 7, 2011 /PRNewswire/ -- Aethlon Medical, Inc. (OTCBB: AEMD), the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announces that Chairman and CEO James A. Joyce will provide a company overview, discuss recent developments and review upcoming milestones at the 5th LHA Life Sciences & Medical Technologies Virtual Conference. (Photo: http://photos.prnewswire.com/prnh/20090325/LA88762LOGO-b) The webcast presentation will be...

2011-06-02 06:11:00

SAN DIEGO, June 2, 2011 /PRNewswire/ -- Aethlon Medical, Inc. (OTCBB: AEMD) today announced that Company President Rodney S. Kenley will discuss the role of the Aethlon Hemopurifier® in the treatment of hepatitis C virus (HCV) in an upcoming presentation at the 20th International Vicenza Course of Hemodialysis and CKD (chronic kidney disease) on Wednesday, June 8, 2011 in Vicenza, Italy. The Aethlon Hemopurifier® is a first-in-class therapeutic...

2011-05-23 08:11:00

SAN DIEGO, May 23, 2011 /PRNewswire/ -- Aethlon Medical, Inc. (OTC Bulletin Board: AEMD), the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announces that Chairman and CEO James A. Joyce will present the Aethlon ADAPT(TM) system in a presentation at the C21 BioVentures(TM) Life Sciences Partnering Conference on Wednesday, May 26, 2011, at 3:00 p.m. Pacific time at the Meritage Resort in Napa, Calif. The newly introduced Aethlon ADAPT(TM)...

2011-05-19 08:12:00

SAN DIEGO, May 19, 2011 /PRNewswire/ -- Aethlon Medical, Inc. (OTCBB: AEMD) announces the introduction of the Aethlon ADAPT(TM) system, an adaptive dialysis-like affinity platform technology that provides a novel and potentially expedited commercialization pathway for monoclonal antibodies and other affinity drug agents. The platform technology allows for single or multiple biologic agents to be immobilized within a therapeutic filtration design that results in a significantly less...

2011-05-09 08:15:00

SAN DIEGO, May 9, 2011 /PRNewswire/ -- Aethlon Medical, Inc. (OTCBB: AEMD) announces that it has submitted a request to the U.S. Food and Drug Administration (FDA) for a face-to-face meeting to discuss re-initiation of an Investigational Device Exemption (IDE) study of the Aethlon Hemopurifier® in the United States. As part of these discussions, Aethlon management will present FDA officials with new clinical data that supports the safety of the...

2011-04-20 15:27:00

SAN DIEGO, April 20, 2011 /PRNewswire/ -- Earlier today, Aethlon Medical, Inc. (OTCBB: AEMD) disclosed that it was the subject of an ABC affiliate station news story that included discussion of the company's proposed strategy to reduce the occurrence of sepsis in wounded military personnel. As previously disclosed, the company submitted a contract response on April 1, 2011 to a Broad Agency Announcement (BAA) entitled Dialysis Like Therapeutics (DLT). In the submission, company proposed...

2011-04-20 08:30:00

SAN DIEGO, April 20, 2011 /PRNewswire/ -- Aethlon Medical, Inc. (OTCBB:AEMD), the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, disclosed today that it is the subject of an ABC news story that can be accessed online at: http://www.10news.com/news/27605561/detail.html (Photo: http://photos.prnewswire.com/prnh/20090325/LA88762LOGO-b) About Aethlon Medical At Aethlon Medical, we create revolutionary devices to address infectious disease and...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'